Anticoagulation Forum
@AnticoagForum
We are a member organization of physicians, pharmacists & nurses dedicated to education, expertise, stewardship & excellence in anticoagulant therapy.
ID:889009832
http://acforum.org 18-10-2012 14:46:33
4,0K Tweets
5,4K Followers
4,7K Following
Y’all this is huge for pharmacists and team-based care in KY!!!! American College of Cardiology #ACCCVT ACCP Cardiology PRN Anticoagulation Forum GTMRx Institute
The debate of CDT vs AC continues for intermediate-risk PE, but promising early results favoring CDT #thrombosis #clotchat pubmed.ncbi.nlm.nih.gov/36260302/ PERT Consortium North American Thrombosis Forum Thrombosis UK Thrombosis Canada CanVECTOR Network European Society of Cardiology European Thrombosis & Haemostasis Alliance (ETHA) Anticoagulation Forum ISTH
There are now -> FIVE <- sites in US on path to establish PGY2 Residencies in Thrombosis and Hemostasis Management. Check out this funding opportunity to jump on the TRAIN! All aboard! allison burnett Anticoagulation Forum APPLY NOW!
Then we looked at the over 9000 pts on DOACs in that cohort. We did not find a signif difference in risk of ICH between the different DOACs examined (apix, dabi, riva). See the study in Thrombosis Research here:
thrombosisresearch.com/article/S0049-…
Vic Tapson discussing dilemmas in anticoagulation management in obese patients. You may be surprised with these facts. PERT Consortium CHEST Parth Rali #CHEST2022
True! Huge problem most if not all hospitals have, & very little self-awareness. Stewardship needed around 1)patient edu on #VTE risk 2) RN empowerment to intervene 3) escalation process to engage providers 4) data tracking & continuous QI. 성정호 looking to Johns Hopkins University model👍🏼
We’ve relied on 2020 data for #COVID19 associated #thrombsosis . Little known RE effects of new #viral variants, #vaccines 💉, and #antiviral therapies until lately. Azita Talasaz et al nicely illustrates this until 02/2022. Data emerging now for epi, and for treatment effect of💊.
Rivaroxaban monotherapy in patients with acute PE
The #RIETEregistry experience
Here: ncbi.nlm.nih.gov/pmc/articles/P…
Management of PE symposium for Thrombosis UK to celebrate World Thrombosis Day
Dr. Raza Ali Khan gives a superb talk in managing low risk PE - & shows us how DOACs have become the anticoagulant of choice in this group in NHS England
#ManagementofPE
Thrombosis UK
World Thrombosis Day
Narayan Karunanithy points out how Intermediate risk PE management may be following the trend seen in MI & ischaemic stroke- moving from thrombolysis to mechanical thrombectomy
While some #patients are on #bloodthinners will be on for life, others may come off in as little as 3 months. If it's been 3+ months since you've been put on a blood thinner, consider discussing with your doctor when is best to come off. #thrombosis #ThrombosisTipTuesday
